{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:09:50Z","timestamp":1761883790158,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.reumae.2020.05.005","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T01:40:16Z","timestamp":1612662016000},"page":"521-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-phosphatidylserine\/prothrombin antibodies in patients with polyarteritis nodosa"],"prefix":"10.1016","volume":"17","author":[{"given":"Susy Marcela","family":"S\u00e1nchez-Cub\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Mart\u00edn-Nares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Hern\u00e1ndez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Nu\u00f1ez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Antonio","family":"Sedano-Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel Gabriel","family":"Vargas-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Hinojosa-Azaola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2020.05.005_bib0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","article-title":"Polyarteritis nodosa: A contemporary overview","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmn Rev."},{"key":"10.1016\/j.reumae.2020.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.23081","article-title":"High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous Polyarteritis Nodosa","volume":"57","author":"Kawakami","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reumae.2020.05.005_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MD.0b013e3182115508","article-title":"Correlation of livedo racemosa, cutaneous inflammatory plaques, and antiphospholipid antibodies in patients with cutaneous Polyarteritis Nodosa","volume":"90","author":"Kawakami","year":"2011","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.reumae.2020.05.005_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/1346-8138.13491","article-title":"Presence of anti-phosphatidylserine-prothrombin complex antibodies and anti-moesin antibodies in patients with polyarteritis nodosa","volume":"44","author":"Okano","year":"2017","journal-title":"J Dermatol."},{"key":"10.1016\/j.reumae.2020.05.005_bib0025","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reumae.2020.05.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reumae.2020.05.005_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2020.05.005_bib0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch\u2013Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2020.05.005_bib0045","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International Study Group for Beh\u00e7et\u2019s Disease","volume":"335","author":"Wechsler","year":"1990","journal-title":"Lancet."},{"key":"10.1016\/j.reumae.2020.05.005_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.reumae.2020.05.005_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00296-017-3706-5","article-title":"Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa","volume":"37","author":"Oh","year":"2017","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reumae.2020.05.005_bib0060","first-page":"31","article-title":"Development and validation of a disease extent index for Wegener\u2019s granulomatosis","volume":"55","author":"De Groot","year":"2001","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.reumae.2020.05.005_bib0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reumae.2020.05.005_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.thromres.2018.12.023","article-title":"Prevalence and associations of anti-phosphatidylserine\/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS\/PT antibodies in primary antiphospholipid syndrome","volume":"174","author":"N\u00fanez-Alvarez","year":"2019","journal-title":"Thromb Res."}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:59:59Z","timestamp":1761879599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574321000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2173574321000198"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2020.05.005","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-phosphatidylserine\/prothrombin antibodies in patients with polyarteritis nodosa","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2020.05.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}